01.11.2012 Views

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

notes to the financial statements – DECEMBER 31, 2001<br />

These notes form an integral part of and should be read in conjunction with the accompanying financial statements.<br />

1. GENERAL<br />

The Company is incorporated in the Republic of Singapore with its principal place of business at:<br />

400 Orchard Road #11-11<br />

Orchard Towers<br />

Singapore 238875<br />

However, the registered office of the Company is at:<br />

17 Phillip Street #05-01<br />

Grand Building<br />

Singapore 048695<br />

The financial statements are expressed in Singapore dollars.<br />

The principal activities of the Company which is incorporated in Singapore are to act as importers, exporters, wholesalers, retailers,<br />

manufacturers, manufacturers’ agents and representatives, marketing agents, commission agents, distributors of medicinal and<br />

pharmaceutical products, health care, beauty care, toiletries and related items and provision of services to related corporations.<br />

The financial statements of the Company for the year ended December 31, 2001 were authorised for issue by Board of Directors<br />

at their meeting held on March 12, 2002.<br />

2. SIGNIFICANT ACCOUNTING POLICIES<br />

2.1 Basis of accounting<br />

The financial statements are prepared in accordance with the historical cost convention and the provisions of the Singapore<br />

Statements of Accounting Standard (“SAS”) and Singapore Companies Act.<br />

The immediate holding Company and related companies have provided financial support to the Company and the Directors<br />

are satisfied that they will continue to provide such support so as to enable the Company to meet its obligations as and when<br />

they fall due.<br />

The Company has adopted all the applicable new/revised SAS which becomes effective during the financial year. The adoption<br />

of the new/revised SAS does not affect the results of current financial year.<br />

2.2 Revenue recognition<br />

Revenue from sale of goods is recognised upon passage of title to the customer which coincides with their delivery and<br />

acceptance.<br />

Interest income is recognised on an accrual basis.<br />

Management fee income is based on service rendered.<br />

2.3 Fixed assets<br />

Fixed assets are stated at cost less accumulated depreciation. The cost of an asset comprises its purchase price and any directly<br />

attributable costs of bringing the asset to working condition for its intended use. Expenditure for additions, improvements and<br />

renewals are capitalised and expenditure for maintenance and repairs are charged to the Profit and Loss Statement. When<br />

assets are sold or retired, their cost and accumulated depreciation are removed from the accounts and any gain or loss resulting<br />

from their disposal is included in the Profit and Loss Statement.<br />

2.4 Depreciation<br />

Depreciation is calculated on a straight line method to write off the cost of the assets over their estimated useful lives. The<br />

estimated useful lives of fixed assets are as follows:<br />

Years<br />

Furniture & fixtures 5<br />

Office equipment 5<br />

Computers 3<br />

Fully depreciated assets are retained in the accounts until they are no longer in use and no further charge for depreciation is<br />

made in respect of these assets.<br />

REDDY PHARMACEUTICALS SINGAPORE PTE LTD. | FINANCIALS | ANNUAL REPORT 2001<br />

237

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!